The H1 2022 New York Healthcare Funding Report is out!
The heady days of 2021 have faded and a new reality has set in. While stock prices and valuations are down and fewer deals abound, H1 2022 was a time when entrepreneurs and their investors took the time to focus on fundamentals and learn the importance of managing costs and proving the business model.
It’s also important to maintain perspective on the current market. While numbers are certainly down from 2021, they are still ahead of H1 2020 and far greater than 2019. There was a total of $2.4B raised across 85 companies in the first half of 2022.
In our latest report, hear how the first half of the year shaped up for New York’s healthcare industry. Download the report now for more insights and analysis.